control
crystal
crystallization
crystals
delivery
development
drug
engineering
equipment
high
inhaled
manufacture
manufacturing
medicines
oxford
particle
particles
pharmaceutical
power
process
processing
product
products
proprietary
prosonix
respiratory
scale
science
size
technologies
technology
ultrasonic
ultrasound
used
using
| Prosonix Features on WebTV |
 |
 |
 |
| Friday, 19 December 2008 11:41 |
|
             |
| Last Updated on Saturday, 17 January 2009 15:52 |
David Hipkiss Prosonix CEO discusses the benefits of the Prosonix Sonocrystallization technology for the preparation of microcrystalline and mescopic particles of Active Pharma Ingredients with Nick Taylor of Inpharmatechnologist.com
Navigation
Latest News
03 Feb 2012 - Geoff Down appointed as Chief Medical Officer
Prosonix Appoints Respiratory Drug Development Expert Dr Geoff Down as Chief Medical Officer Prosonix (Oxford, UK), an emerging pharmaceutical company developing a portfolio of enhanced respiratory...
Prosonix Appoints Respiratory Drug Development Expert Dr Geoff Down as Chief Medical Officer Prosonix (Oxford, UK), an emerging pharmaceutical company developing a portfolio of enhanced respiratory...
More in: Latest
